Financial News · Live Terminal

Page 412 of 857

ISDN Unit Launches High-Speed Laser Marker for Chip Packaging

ISDN's (HKG:1656, SGX:I07) subsidiary, IDI Dynamics, launched a high-speed laser marker for semiconductor chip packaging and testing applications, according to a Tuesday Hong Kong bourse filing.The company said the new laser marker delivers up to 2.5 times higher marking speed while occupying 22% less cleanroom floor space compared with widely used industry configurations, the filing said.

HKG:1656SGX:I07

Asia45d ago

Commonwealth Bank of Australia's AI-Powered 'CommBank Companion' Enters Application Testing

Commonwealth Bank of Australia (ASX:CBA) has started trialing "CommBank Companion," a generative artificial intelligence tool embedded in its mobile banking app that lets retail and business customers ask questions, track finances, and receive real-time insights to help manage spending, budgeting, and cash flow, according to a Tuesday statement by the bank.The system enables users to understand and manage their finances through natural-language queries within a secure banking environment governed by strict privacy, safety, and risk controls.The tool is initially being tested with employees and selected business banking customers, with wider customer testing planned, and is intended to support decision-making rather than provide financial advice or act on users' behalf.The bank's shares fell 1% in recent Tuesday trade.

ASX:CBA

Asia45d ago

Unitree Robotics Nears 4.2 Billion Yuan Shanghai IPO

The Shanghai Stock Exchange's Listing Review Committee will review the initial public offering application of Unitree Robotics on June 1, according to an announcement on Monday.Unitree filed its IPO application in March, seeking to raise up to 4.2 billion yuan.The company plans to use the proceeds for research and development of intelligent robot models and hardware, the rollout of new intelligent robot products, and the construction of a manufacturing base.CITIC Securities (SHA:600030, HKG:6030) serves as the sponsor for the IPO.The company posted an attributable profit of 590 million yuan and revenue of 1.70 billion yuan for 2025.

Shanghai Composite^SZSEHKG:6030SHA:600030

Asia45d ago

NZX Midday Sector Update: Health Technology Rises, Commercial Services Tank

Health technology stocks gained the most on New Zealand's Exchange, rising nearly 6% by midday Tuesday.Fisher & Paykel Healthcare (NZE:FPH, ASX:FPH) shares climbed almost 7% in recent trade.The company reported Tuesday fiscal 2026 underlying earnings of NZ$0.793 per share, up from NZ$0.639 a year earlier.Meanwhile, the commercial services sector declined past 1%.PGG Wrightson (NZE:PGW) was down past 3% in recent trade.

^NZ50ASX:FPHNZE:FPHNZE:PGW

Asia45d ago

Xingye Silver & Tin Mining Applies for Hong Kong Listing

Inner Mongolia Xingye Silver & Tin Mining (SHE:000426) applied for the listing and offering of shares on the Hong Kong Stock Exchange on Monday, according to a Tuesday filing on the Shenzhen bourse.The Chinese mining company's shares fell by over 2% during the morning trade.

SHE:000426

Asia45d ago

Adveritas Says ARR Rises 8% in June Quarter To-Date

Adveritas (ASX:AV1) said its annualized recurring revenue (ARR) reached AU$16.3 million within the first two months of the June quarter, an increase of 8% from AU$15.08 million in around two months from March 31, according to a Tuesday Australian bourse filing.The majority of new ARR added in the quarter to date has been derived from new US-based organizations outside of its established sports betting and online gaming segments, per the filing.It said 652 sign-ups were registered with the TrafficGuard small and mid-sized enterprise self-serve platform to date since its launch on April 1, and 54 billable accounts were now active as paying subscribers. 120 advertisers were on active trial under the 30-day free trial period.Its shares rose 2% in recent trading on Tuesday.

ASX:AV1

Asia45d ago

CanSino Biologics Begins Trials of Broad Pneumococcal Conjugate Vaccine

CanSino Biologics (HKG:6185, SHA:688185) initiated a phase 1/2 trial of its 24-valent pneumococcal conjugate vaccine, a broad-spectrum shot designed to prevent infections caused by 24 pneumococcal serotypes, according to a Tuesday filing with the Hong Kong bourse.The trial will evaluate the vaccine in subjects aged two months and older for the prevention of pneumococcal infections, which can cause diseases such as pneumonia and meningitis.The new product could expand coverage beyond the company's existing 13-valent pneumococcal vaccine, which was approved in China in June 2025.The firm said there were currently no 24-valent pneumococcal conjugate vaccines available on the global market.

HKG:6185SHA:688185

Asia45d ago

Viva Leisure Upgrades Fiscal 2026 Net Profit After Tax Guidance; Shares Gain 8%

Viva Leisure (ASX:VVA) raised its fiscal 2026 guidance for both statutory and underlying net profit after tax (NPAT), citing strong margin discipline and improving contribution from its technology, payments, licensing and retail division, according to a Tuesday filing with the Australian bourse.The company upgraded its statutory NPAT guidance to more than AU$12 million from a prior forecast of more than AU$11.5 million, and raised its underlying NPAT outlook to more than AU$17 million from over AU$16 million.Viva Leisure maintained its fiscal 2026 revenue guidance at greater than AU$237 million.The company's shares advanced more than 8% in recent Tuesday trade.

ASX:VVA

Asia45d ago

China Medical System Gets China Trial Approval for Crohn's, Colitis Drug

China Medical System's (HKG:0867, SGX:8A8) said China's National Medical Products Administration approved clinical trials of its self-developed TYK2 inhibitor CMS-D001 for ulcerative colitis and Crohn's disease, according to a Tuesday Hong Kong bourse filing.The company said CMS-D001 is being developed for inflammatory bowel disease indications, including ulcerative colitis and Crohn's disease, and may also be developed for autoimmune conditions such as systemic lupus erythematosus in the future.

HKG:0867SGX:8A8

Asia45d ago

Beacon Minerals Receives 'Encouraging' Results From Western Australia Deposit

Beacon Minerals (ASX:BCN) received "encouraging" results from a further 124 reverse circulation holes from drilling at the Iguana deposit within the Lady Ida project in Western Australia, according to a Tuesday filing with the Australian bourse.Results include 19 meters at 12 grams per tonne (g/t) grade of gold from 111 meters, including 1 meter at 152 g/t grade of gold from 111 meters, and 5 meters at 21 g/t grade of gold from 165 meters, including 1 meter at 96 g/t grade of gold from 166 meters, the filing said.Assays are still being received, and a disclosure will be made once all results are returned, per the filing.Shares fell 2% in morning trade Tuesday.

ASX:BCN

Asia45d ago

Okura Invests $4 Million in Fund Targeting U.S. Aerospace Tech Firm

Okura (HKG:1655) agreed to invest nearly $4.1 million in an undisclosed U.S.-based fund targeting a privately held aerospace and technology company, according to a Tuesday Hong Kong bourse filing.The pachinko hall operator said the investment will allow the group to diversify its revenue stream and participate in global securities markets through professional fund management.

HKG:1655

Asia45d ago

Virgin Australia's 150th Boeing 737 Jet Enters Service; Shares Fall 3%

Virgin Australia (ASX:VGN) said it 150th Boeing 737 jet has officially entered service, marking a fleet renewal milestone, according to a Tuesday statement.The latest aircraft, named Lake Centenary, is the 100th Boeing 737 plane in Virgin Australia's current fleet and the 150th 737 received by the airline in the last 26 years.Virgin Australia said it will receive a dozen 737-8s this year, along with four Embraer E190 E2s for its regional Australian flights.The company's shares were down 3% in recent Tuesday trade.

ASX:VGN

Asia45d ago

Santos to Target Capital Expenditure Reduction of Around AU$300 Million from 2027 to 2030

Santos (ASX:STO) is set to prioritize upstream investment in the Moomba Central fields area in South Australia and deprioritize the broader Cooper Basin, targeting cumulative capital expenditure reduction of around AU$300 million from 2027 to 2030, and AU$150 million savings annually thereafter, according to a Tuesday Australian bourse filing.This came amidst the firm's strategic review of its Australian domestic oil and gas business.It also said its machine learning bottom-hole pressure model, replacing physical downhole gauges, could lead to around AU$70 million in potential capital expenditure reduction.Its shares rose 1% in recent trading on Tuesday.

ASX:STO

Asia45d ago

Momentum Financial Launches HK$21 Million Share Placement to Fund E-Commerce, Web3 Push

Momentum Financial (HKG:1152) plans to raise net proceeds of about HK$20.5 million through a share placement, according to a Tuesday Hong Kong bourse filing.The company agreed to place up to 104.3 million new shares at HK$0.20 apiece, representing discounts of 20% to the last closing price and 18.6% to the five-day average closing price.The new shares represent about 3.1% of the company's existing issued share capital and about 3% of the enlarged share capital after the placement.Momentum Financial said about 73% of the proceeds will be used for cross-border e-commerce businesses, while the remainder will fund AI- and Web3-driven e-wallet payment solutions and general working capital.

HKG:1152

Asia45d ago

Tsaker New Energy Unit's Beijing Exchange Listing Approved by Bourse

Tsaker New Energy Tech's (HKG:1986) plan to list Hebei Tsaker New Materials Technology in China is progressing after the Beijing Stock Exchange approved the public offering, according to a Tuesday filing with the Hong Kong bourse.The firm plans to offer around 8 million new Hebei Tsaker shares at 30.28 yuan each during the IPO. The shares represent 12.54% of the business' issued share capital and 11.15% as enlarged by the transaction.Results from the offering will be due by June 1.The firm said it will offer 797,480 shares from the broader IPO to certain strategic investors, including three of its directors, Liu Wei, Ren Quansheng, and Xu Yanxia.

HKG:1986

Asia45d ago

Worley Secures Engineering Services Contract From AEP for Oklahoma Gas Turbine Project

Worley (ASX:WOR) was awarded an engineering services contract by American Electric Power (AEP) to support stages 3 to 4 of the Northeastern Simple Cycle Gas Turbine project at Public Service Company of Oklahoma's Northeastern generation facility in the US, according to a Tuesday filing with the Australian bourse.The scope includes engineering, detailed design, and procurement support for a new natural gas-fired power plant consisting of two gas turbines with a total capacity of around 450 megawatts, per the filing.The project will be executed under the company's master services agreement with AEP, led from its Reading, Pennsylvania, office with support from its global integrated delivery team and offices in Louisiana and Houston, the filing added.

ASX:WOR

Asia45d ago

Beijing Shougang LanzaTech Seeks Up to HK$684 Million in Hong Kong IPO

Beijing Shougang LanzaTech (HKG:2553) launched its Hong Kong initial public offering on Tuesday, seeking to raise up to HK$684 million from the deal.The China-based carbon capture, utilization, and storage technology company is offering 40.0 million shares at an indicative maximum price of HK$17.10 per share, according to a Hong Kong bourse filing.The offering comprises 4 million shares for Hong Kong investors and 36 million shares for international investors, subject to reallocation and the overallotment option.The offer price is expected to be determined by June 1, with allocation results due by June 2, ahead of the company's planned trading debut on June 3.Net proceeds will be used mainly to fund the construction and development of production facilities in Hebei and Inner Mongolia, including a sustainable aviation fuel facility.The funds will also be used for research and development, technology upgrades at existing production facilities, new product development, strategic investments, and working capital and general corporate purposes.Yue Xiu Capital is acting as the sole sponsor, while Yue Xiu Securities is serving as the overall coordinator and joint global coordinator alongside Mango Financial.Yue Xiu Securities, Mango Financial, Maxa Asset Management, CCB International Capital, Skyvast Securities, GEO Securities, uSmart Securities, CMBC Securities, Futu Securities International (Hong Kong), and Livermore are acting as joint bookrunners and joint lead managers.The company had earlier shelved the listing timetable after a legal dispute involving the joint venture Shoulang Jiyuan disrupted the offering process and rendered the previous prospectus ineffective.The case stems from a June 2025 lawsuit filed by a minority shareholder alleging unauthorized capital and pricing decisions at the venture.Shougang LanzaTech has dismissed the allegations as baseless and said the dispute is not expected to materially affect its operations or financial position.

HKG:2553

Asia45d ago

Update: Infratil Swings to Fiscal 2026 Profit, Posts Higher Revenue; Shares Fall 5%

(Updates to add stock movement in the headline and last paragraph)Infratil (ASX:IFT, NZE:IFT) reported Tuesday that it swung to a profit of NZ$0.558 per share in the fiscal 2026 from a loss of NZ$0.315 a year earlier.Revenue for the 12 months ended March 31 was NZ$3.04 billion, compared with NZ$2.86 billion a year earlier. Analysts surveyed by FactSet expected NZ$3.39 billion.The company expects fiscal 2027 proportionate operational earnings before interest, tax, depreciation, amortization, and fair value adjustments of NZ$1.3 billion to NZ$1.4 billion, up 21% at the midpoint from NZ$1.11 billion in fiscal 2026 on a like-for-like basis, with proportionate capital expenditure of NZ$3.8 billion to NZ$4.4 billion.The board declared a final dividend of NZ$0.1365 per share, up from NZ$0.1325 a year earlier, payable June 29 to shareholders on record as of June 10.The company's shares fell 5% on both the New Zealand and Australian exchanges in Tuesday's trading session.

ASX:IFTNZE:IFT

Asia45d ago

Update: Fisher & Paykel Healthcare Posts Higher Fiscal 2026 Underlying Earnings, Revenue; Shares Up 7%

(Updates to add stock movement in the headline and last paragraph)Fisher & Paykel Healthcare (ASX:FPH, NZE:FPH) reported Tuesday fiscal 2026 underlying earnings of NZ$0.793 per share, up from NZ$0.639 a year earlier.Analysts polled by FactSet expected earnings of NZ$0.80.Operating revenue for the 12 months ended March 31 was NZ$2.31 billion, compared with NZ$2.02 billion a year earlier. Analysts surveyed by FactSet expected NZ$2.3 billion.The company expects fiscal 2027 operating revenue to range from around NZ$2.45 billion to NZ$2.57 billion, with net profit after tax projected to be between NZ$500 million and NZ$550 million. Analysts polled by FactSet expect revenue of NZ$2.56 billion.The board declared a final dividend of NZ$0.33 per share, up from NZ$0.24 a year earlier, payable July 3 to shareholders on record as of June 23.The company's shares rose 7% on both the New Zealand and Australian exchanges in Tuesday's trading session.

ASX:FPHNZE:FPH

Asia45d ago

ASX Issues Fiscal Year 2027 Expense Growth Guidance, Raises Capex Outlook; Shares Fall 12%

ASX (ASX:ASX) said it expects fiscal year 2027 expenses to grow between 18% and 21% from fiscal year 2026, while operating expenses excluding depreciation and amortization are forecast to rise 13% to 16%, according to a Tuesday filing with the Australian bourse.The company said the forecast for higher expenses is mainly driven by technology modernization, and changes it is making in response to an inquiry by the Australian Securities and Investments Commission that flagged certain governance and risk management failures.ASX increased its fiscal year 2027 capital expenditure guidance to between AU$180 million and AU$200 million from a previous range of AU$160 million to AU$180 million, primarily driven by technology cost inflation and new product development. The company also disclosed fiscal year 2028 capital expenditure guidance of between AU$170 million and AU$190 million.Additionally, ASX adjusted its medium-term target range for underlying return on equity to between 12% and 14% from a previous target of 12.5% to 14%. The company kept its dividend policy intact with a payout ratio range of 75% to 85% of underlying net profit after tax.Meanwhile, the stock exchange operator struck a deal to sell its 49% stake in Sympli to its joint venture partner, ATI Group, for a nominal amount. The sale will result in an after-tax loss of about AU$12 million in fiscal year 2026.ASX shares fell 12% in recent Tuesday trade.

ASX:ASX

Showing 8221-8240 of 17121

Asia45d ago

Beijing Shougang LanzaTech Seeks Up to HK$684 Million in Hong Kong IPO

HKG:2553